Worth reading
55In focus
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
274119
unitsWording
Conditional
How definitive the wording is.Details of issuance or disposal
Partial acquisition and cancellation of Series 19 Stock Acquisition Rights through a third-party allotment
Terms of the stock acquisition rights
Exercise price
¥209 (fixed; no exercise price adjustment clause)
Number of Stock Acquisition Rights
392,347 rights issued in total; 274,119 rights to be acquired and cancelled; 82,000 rights remaining after cancellation
Reason for acquisition without consideration
Application of the acquisition provision under the issuance terms
Most recent equity financing
Timing 26 February 2026 / Type Issuance of new shares and the 19th Series Stock Acquisition Rights through a third-party allotment / Amount Not disclosed
Impact on Business Performance
The impact on consolidated results and other matters for the fiscal year ending August 2026 will be minor
| Item | Details |
|---|---|
| Type of issuance or disposal | Partial acquisition and cancellation of Series 19 Stock Acquisition Rights through a third-party allotment |
| Exercise price | ¥209 (fixed; no exercise price adjustment clause) |
| Number of Stock Acquisition Rights | 392,347 rights issued in total; 274,119 rights to be acquired and cancelled; 82,000 rights remaining after cancellation |
| Reason for acquisition without consideration | Application of the acquisition provision under the issuance terms |
| Most recent equity financing | Timing 26 February 2026 / Type Issuance of new shares and the 19th Series Stock Acquisition Rights through a third-party allotment / Amount Not disclosed |
| Impact on Business Performance | The impact on consolidated results and other matters for the fiscal year ending August 2026 will be minor |
Items this document does not state (22)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The fixed exercise price of ¥209 has remained below the market share price, making it difficult to raise funds flexibly as originally envisaged. As the Company moves to new refinancing, allowing the Series 19 Stock Acquisition Rights to remain outstanding in parallel could result in an increase in the number of potential shares and overlapping dilution risk.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.